IINN - Rasio utang marang kapitalisasi buku inspira-technologies.com

Logo korporat perusahaan Inspira Technologies Oxy B.H.N. Ltd (IINN)

Inspira Technologies Oxy is mitigating risks through the global implementation of non-invasive respiratory support systems. The company's ratio of financial debt to equity clearly illustrates its financial stability, with the indicator standing at 0.62. The market launch of ART technology and FDA approval will drive growth, while current quotes already price in development costs and regulatory complexities.

Inspira Technologies Oxy B.H.N. Ltd. - Utang-utang marang kapitalisasi buku IINN (periode 04.07.2022 - 20.05.2026)
Barang unggulan Inspira Technologies Oxy B.H.N. Ltd.

A comparative asset analysis allows for an assessment of capital structure stability through the debt-to-equity ratio. This metric measures the proportion of borrowed funds relative to the company's book value, where the value 0.62 reflects the current level of financial leverage. For Inspira Technologies (IINN), this is critical due to unstable cash flows during the equipment commercialization stage. An increase in this indicator signals risks in the event of certification delays. By analyzing the current ratio of debt to book capital, an investor determines the business's margin of safety.

Pesaing Inspira Technologies Oxy

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI (Zynex Inc)|Utang marang nilai buku electrocore.com (ECOR)|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku